Selectis Health (GBCS) Long-Term Deferred Tax (2014 - 2021)

Selectis Health has disclosed Long-Term Deferred Tax across 8 years of filings, most recently posting $4.2 million for Q4 2021.

• Long-Term Deferred Tax for Q4 2021 came in at $4.2 million, up 15.15% year-over-year; the trailing twelve-month figure through Dec 2021 was $4.2 million (up 15.15% YoY), and the FY2021 annual result was $4.2 million, up 15.15% from the prior year.
• Long-Term Deferred Tax came in at $4.2 million for Q4 2021 at Selectis Health, up from $3.7 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $13.0 million in Q4 2018 to a low of $3.7 million in Q4 2020.
• The 5-year median for Long-Term Deferred Tax is $12.4 million (2017), against an average of $9.2 million.
• Across the five-year window, Long-Term Deferred Tax plunged 70.86% in 2020 and rose 15.15% in 2021, its largest moves.
• Selectis Health's Long-Term Deferred Tax stood at $12.4 million in 2017, then grew by 4.59% to $13.0 million in 2018, then retreated by 3.08% to $12.6 million in 2019, then slumped by 70.86% to $3.7 million in 2020, then grew by 15.15% to $4.2 million in 2021.
• The last three Long-Term Deferred Tax figures came in at $4.2 million (Q4 2021), $3.7 million (Q4 2020), and $12.6 million (Q4 2019), per Business Quant data.